FOR IMMEDIATE RELEASE


                 MAXXIM ANNOUNCES SHAREHOLDER APPROVAL OF MERGER


            CLEARWATER, FL, November 3, 1999 - Maxxim Medical, Inc. (NYSE: MAM)
announced today that, at the special meeting of its shareholders held earlier
today, its shareholders approved the previously announced Agreement and Plan of
Merger, dated as of June 13, 1999, as amended (the "Merger Agreement"), between
Fox Paine Medic Acquisition Corporation and Maxxim, pursuant to which Fox Paine
Medic Acquisition Corporation will be merged with and into Maxxim and each share
of Maxxim common stock (including the associated preferred stock purchase
rights), other than a portion of the shares held by certain officers, directors
and significant shareholders, and shares held by dissenting shareholders, will
be converted into the right to receive $26.00 in cash, without interest (the
"Merger"). More than 66% of the outstanding shares of Maxxim common stock were
voted in favor of approval of the Merger Agreement. Assuming that the various
conditions to closing the Merger and other transactions contemplated by the
Merger Agreement have been satisfied or waived, Maxxim currently expects to
consummate the Merger and the other transactions in mid-November 1999, although
there can be no assurance that the closing will not be later. Promptly following
the closing of the Merger, shareholders will be sent instructions detailing the
necessary steps to surrender their shares of Maxxim common stock and receive the
cash consideration.

      Maxxim Medical, Inc. is a diversified developer, manufacturer, distributor
and marketer of specialty medical products.


      Contact:    Mary Lugris
                  Investor Relations
                  727-561-2100